Table 3. Clinical benefit rate.
Overall | Al-Batran et al (2006a) | Al-Batran et al (2006b) | Keller et al (2004) | O'Brien et al (2004) | |
---|---|---|---|---|---|
No. of patients | 274 | 79 | 33 | 124 | 38 |
CBR, n (%) | 102 (37.2) | 30 (38.0) | 8 (24.2) | 37 (29.8) | 27 (71.1) |
95% CI | 32.4–42.0 | 29.0–47.0 | 12.0–36.5 | 23.1–36.6 | 59.0–83.2 |
No CB, n (%) | 170 (62) | 49 (62) | 25 (75.8) | 85 (68.5) | 11 (28.9) |
NE, n (%) | 2 (0.7) | — | — | 2 (1.6) | — |
Abbreviations: CBR=clinical benefit rate; CB=clinical benefit; NE=not evaluable for clinical benefit.